Acute Graft Rejection
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
GenomicsTruGraf liver gene expression
AstellasTacrolimus
Clinical Trials (2)
Total enrollment: 501 patients across 2 trials
Diagnosis of Graft Pathology by TruGraf
Start: Jul 2024Est. completion: Dec 2027471 patients
N/ARecruiting
A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf
Start: Jun 2011Est. completion: Oct 201930 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 501 patients
2 companies competing in this space